Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Schachter

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Investigative Ophthalmology & Visual Science|November 1, 2011
Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markersNur Khatib, Jacob Pe'er, Rona Ortenberg, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 7, 2004
Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?Gideon Marshak, Erica Rakowsky, Jacob Schachter, et al.
Plos One|November 19, 2011
Mutagen-specific mutation signature determines global microRNA bindingEyal Greenberg, Gideon Rechavi, Ninette Amariglio, et al.
Melanoma Research|May 21, 2009
Germline analysis of thymidine/guanidine polymorphism at position 309 of the Mdm2 promoter in malignant melanoma patientsIris Gluck, Amos J Simon, Raphael Catane, et al.
Frontiers in Immunology|January 25, 2021
Genetic Modification of Tumor-Infiltrating Lymphocytes <i>via</i> Retroviral TransductionHadas Weinstein-Marom, Gideon Gross, Michal Levi, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanomaJacob Schachter, Uriel Katz, Arie Mahrer, et al.
Melanoma Research|August 12, 2004
Sentinel node guided surgery for melanoma in the head and neck regionThomas Shpitzer, Karl Segal, Jacob Schachter, et al.
Oncology Reports|October 10, 2003
Older age and second skin cancer as prognostic factors in localized malignant melanomasBaruch Brenner, Sara Borok, Erica Rakowsky, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Clinical & Developmental Immunology|July 11, 2012
Novel anti-melanoma immunotherapies: disarming tumor escape mechanismsSivan Sapoznik, Ohad Hammer, Rona Ortenberg, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Investigative Ophthalmology & Visual Science|November 1, 2011
Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markersNur Khatib, Jacob Pe'er, Rona Ortenberg, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|October 7, 2004
Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?Gideon Marshak, Erica Rakowsky, Jacob Schachter, et al.
Plos One|November 19, 2011
Mutagen-specific mutation signature determines global microRNA bindingEyal Greenberg, Gideon Rechavi, Ninette Amariglio, et al.
Melanoma Research|May 21, 2009
Germline analysis of thymidine/guanidine polymorphism at position 309 of the Mdm2 promoter in malignant melanoma patientsIris Gluck, Amos J Simon, Raphael Catane, et al.
Frontiers in Immunology|January 25, 2021
Genetic Modification of Tumor-Infiltrating Lymphocytes <i>via</i> Retroviral TransductionHadas Weinstein-Marom, Gideon Gross, Michal Levi, et al.
Annals of the New York Academy of Sciences|October 4, 2007
Efficacy and safety of intravenous immunoglobulin in patients with metastatic melanomaJacob Schachter, Uriel Katz, Arie Mahrer, et al.
Melanoma Research|August 12, 2004
Sentinel node guided surgery for melanoma in the head and neck regionThomas Shpitzer, Karl Segal, Jacob Schachter, et al.
Oncology Reports|October 10, 2003
Older age and second skin cancer as prognostic factors in localized malignant melanomasBaruch Brenner, Sara Borok, Erica Rakowsky, et al.
Immunotherapy|December 22, 2012
Adoptive T-cell transfer in melanomaOrit Itzhaki, Daphna Levy, Dragoslav Zikich, et al.
Clinical & Developmental Immunology|July 11, 2012
Novel anti-melanoma immunotherapies: disarming tumor escape mechanismsSivan Sapoznik, Ohad Hammer, Rona Ortenberg, et al.
Pageof 16